Peter Koelblinger Selected Research

Peter Koelblinger Research Topics

Disease

19	Melanoma (Melanoma, Malignant) 04/2024 - 01/2017
9	Neoplasms (Cancer) 12/2023 - 01/2017
3	Neoplasm Metastasis (Metastasis) 12/2023 - 09/2020
1	Inflammation (Inflammations) 05/2023
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Epidermolysis Bullosa 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2017

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 02/2023 - 08/2020
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023 - 01/2017
3	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2023
3	AntibodiesIBA 04/2024 - 01/2019
3	MicroRNAs (MicroRNA)IBA 08/2020 - 11/2019
2	Proteins (Proteins, Gene)FDA Link 09/2020 - 01/2020
2	Member 2 Subfamily B ATP Binding Cassette TransporterIBA 08/2020 - 01/2020
2	Cetuximab (Erbitux)FDA Link 01/2019 - 01/2019
2	binimetinibIBA 08/2017 - 01/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2023
1	trametinibIBA 12/2023
1	dabrafenibIBA 12/2023
1	Amino Acids FDA Link 07/2022
1	adipic acid (adipate)IBA 07/2022
1	CarbohydratesIBA 07/2022
1	SphingomyelinsIBA 07/2022
1	Triglycerides (Triacylglycerol)IBA 07/2022
1	4-cresol sulfateIBA 01/2021
1	beta-AlanineIBA 01/2021
1	CeramidesIBA 01/2021
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2021
1	Sarcosine (Methylglycine)IBA 01/2021
1	tiglylcarnitineIBA 01/2021
1	talimogene laherparepvecIBA 01/2021
1	Cyclin D1IBA 09/2020
1	Histocompatibility Antigens Class IIBA 08/2020
1	Surface Antigens (Surface Antigen)IBA 08/2020
1	InterferonsIBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	Horseradish PeroxidaseIBA 01/2020
1	LuciferasesIBA 01/2020
1	ParaffinIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Bovine Serum AlbuminIBA 01/2020
1	transporter associated with antigen processing (TAP)IBA 01/2020
1	Firefly LuciferasesIBA 01/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020
1	tapasinIBA 01/2020
1	Untranslated Regions (Untranslated Region)IBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 11/2019
1	Daunorubicin (Cerubidine)FDA LinkGeneric 11/2019
1	VemurafenibIBA 01/2018
1	encorafenibIBA 01/2018
1	HhAntag691IBA 01/2018
1	IpilimumabIBA 10/2017
1	Phosphotransferases (Kinase)IBA 08/2017

Therapy/Procedure

10	Therapeutics 04/2024 - 01/2017
4	Immunotherapy 05/2023 - 01/2017
1	Ketogenic Diet 07/2022
1	Injections 01/2021
1	Radiotherapy 01/2019